C4 Therapeutics CCCC
NASDAQ CCCC
$3.13 +0.02 (+0.48%)
At close: Sep 29, 2026 · 4:00 PM EDT

C4 Therapeutics (CCCC) Revenue (2019 - 2026)

Updated

C4 Therapeutics (CCCC) posted Revenue of $6.64 million for Q2 2026, up 2.8% from $6.46 million a year earlier and up 7.9% from the prior quarter.

Analysis

C4 Therapeutics (CCCC) Revenue (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at C4 Therapeutics was $35.04 million, up 2.3% year-over-year; for FY2025, it was $35.95 million, up 1.0% from FY2024.

  • Annual Revenue shows a five-year compound annual growth rate of 1.6% (FY2020 to FY2025).
  • In prior years, C4 Therapeutics' Revenue was $35.58 million in FY2024 (+71.4%), $20.76 million in FY2023 (-33.3%), $31.1 million in FY2022 (-32.1%) and $45.79 million in FY2021 (+37.9%).
  • Quarterly Revenue has run from a low of $2.66 million in Q2 2023 to a high of $20.08 million in Q4 2021 over five years.
  • On a year-over-year basis, Revenue increased in five of the last eight quarters, with growth averaging 32.9%.
  • The strongest year-over-year quarter for Revenue in the past five years was Q2 2024, with growth of 350.7%; the weakest was Q4 2022, with a decline of 85.8%.
  • According to Business Quant data, Revenue for the three prior quarters was $6.15 million (Q1 2026), $11.02 million (Q4 2025) and $11.23 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 C4 Therapeutics 383.47 Mn -546.29 Mn - 6.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.64 Mn
Mar 31, 2026 6.15 Mn
Dec 31, 2025 11.02 Mn
Sep 30, 2025 11.23 Mn
Jun 30, 2025 6.46 Mn
Mar 31, 2025 7.24 Mn
Dec 31, 2024 5.18 Mn
Sep 30, 2024 15.36 Mn
Jun 30, 2024 12.01 Mn
Mar 31, 2024 3.04 Mn
Dec 31, 2023 3.26 Mn
Sep 30, 2023 11.07 Mn
Jun 30, 2023 2.66 Mn
Mar 31, 2023 3.76 Mn
Dec 31, 2022 2.85 Mn
Sep 30, 2022 6.75 Mn
Jun 30, 2022 13.83 Mn
Mar 31, 2022 7.65 Mn
Dec 31, 2021 20.08 Mn
Sep 30, 2021 8.50 Mn
API Access

C4 Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CCCC&period=max&api_key=YOUR_API_KEY